Steve Kafka is a General Partner at S32, where he invests from seed through late-stage across Biotechnology, Medical, Therapeutics, Artificial Intelligence, and Oncology. He is based in Cambridge, Massachusetts, United States, and primarily invests in the United States, with a focus on the Greater Boston Area/New England and California. He serves on the boards of Thrive Earlier Detection Corp. (Executive Chair), ArcherDX, Inc. (Executive Chair), and Relay Therapeutics (Director), and has invested in companies like Function Oncology, BigHat Biosciences, Satellite Bio, ROME Therapeutics, and ImmuneID. Before S32, he was a Partner at Third Rock Ventures; Executive Chair at Thrive Earlier Detection Corp. and ArcherDX, Inc.; Director at Relay Therapeutics; President & Chief Operating Officer at Foundation Medicine; COO & CFO at Aileron Therapeutics; VP, Finance at Infinity Pharmaceuticals; and Senior Director, Finance at Millennium Pharmaceuticals. He attended Harvard University and Stanford University.
Steve Kafka, General Partner @ S32. Profile with intro opportunities and ranking information.
Not Yet Mapped
We've created a profile for Steve Kafka from section 32. Our ranking analysis and additional data will be available once our research is complete.
Rankings and detailed information coming soon
Network Strength
No ranking data available yet.
How to get an intro to Steve
Map your path to Steve instantly
Connect your network and Draftboard will automatically find and score the strongest paths to Steve
That's it. Draftboard does the rest.
Rankings based on connection strength analysis - we ONLY show aggregate data, never specific connection data.